Concurrent aortic stenosis and hypertension: mortality trends in US older adults from 1999-2020

Ahmed Raza1, Fnu Kalpina2, Manayiel Rehmat3

  • 1Department of Medicine, Services Institute of Medical Sciences, Lahore, Punjab, Pakistan.

Future Cardiology
|July 21, 2025
PubMed

Insights

Mortality from aortic stenosis and hypertension is rising in US older adults, particularly among males and non-Hispanic white individuals. Targeted healthcare interventions are crucial to combat this trend.

Area of Science:

  • Cardiology
  • Public Health
  • Gerontology

Background:

  • Aortic stenosis (AS) is a significant valvular heart disease.
  • Hypertension is a known risk factor that accelerates AS progression, increasing patient morbidity and mortality.
  • Understanding mortality trends in older adults with both conditions is crucial for public health initiatives.

Purpose of the Study:

  • To investigate the mortality trends in US adults aged 65 and older diagnosed with aortic stenosis and hypertension between 1999 and 2020.
  • To identify demographic and geographic disparities in mortality rates within this patient population.

Main Methods:

  • Utilized the CDC WONDER database for comprehensive mortality data.
  • Analyzed age-adjusted mortality rates (AAMRs) per 100,000 individuals.
  • Employed Joinpoint regression to calculate annual percent change (APC) and average APC (AAPC) for trend analysis.

Main Results:

  • A significant increasing mortality trend was observed from 1999 to 2020 (AAPC: 5.51%), with hypertension contributing to 99,250 deaths in AS patients.
  • Males exhibited higher AAMRs (11.51) compared to females (9.99).
  • Non-Hispanic white individuals (11.32) had the highest AAMRs, followed by Hispanic (7.37), Non-Hispanic Black (7.27), and Non-Hispanic Asian (6.12) populations. The West region reported the highest AAMR (13.3), and non-metropolitan areas (11.19) showed higher mortality than metropolitan areas (10.49).

Conclusions:

  • Mortality rates for patients with aortic stenosis and hypertension are increasing, with notable disparities observed across demographic groups (males, non-Hispanic white individuals) and geographic regions (the West).
  • These findings underscore the urgent need for targeted healthcare strategies and interventions to mitigate the rising mortality associated with these co-occurring conditions.
Abstract

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
24
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
59
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
38
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
85
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
45
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
41